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Summary Our findings from a previous study, that increased consumption of beta-carotene and vitamin C is
associated with favourable prognostic indices in patients with breast cancer, have been borne out by our
current study of patient survival over a 6-year period. The results of the current study point to beta-carotene
consumption as the dietary variable most significantly associated with improved survival. Only one death
occurred in the group with the highest consumption of beta-carotene, while there were eight and 12 deaths in
the intermediate and lowest groups of consumption respectively. The possible antiproliferative effects of
beta-carotene have been recognised for some time, with investigations being focused more recently on its
derivative, retinoic acid, which has been found to improve differentiation in many tissues, including cell lines
derived from mammary carcinomas. Retinoids have been associated with significant clinical responses in a
variety of tumours, and chemoprevention trials using beta-carotene have been undertaken for many malignan-
cies. However, beta-carotene has not yet been used in clinical trials to evaluate its potential for the treatment
of breast cancer. A large-scale clinical trial is necessary to determine the effectiveness of beta-carotene in
reducing the chances of recurrence of breast cancer, and in preventing the development of new cancers.
There is considerable variation in the growth rate of breast
cancer: in some patients there is rapid progression to death,
while others remain in remission for many years before relap-
sing or continue remission indefinitely. There has been a vast
increase in our knowledge of many of the factors which are
indicators of this progression or otherwise, such as growth
factors, oncogenes and anti-oncogenes. What is still poorly
understood is the role played by the host environment. There
is some evidence that diet may be an important factor, and
this study explores this concept further. If nutritional factors
can be identified, there is considerable potential for using this
information for chemoprevention of breast cancer or as a
modifier of tumour growth in patients with established
cancer.
We previously undertook a study which demonstrated that
an increase in the consumption of sugar, fibre, fruit and
vegetables and some vitamins - in particular beta-carotene
and vitamin C - is associated with favourable breast cancer
growth characteristics (Ingram et al., 1992). Of note were
improvement in the degree of differentiation of the tumours
and an increase in the levels of oestrogen and progesterone
receptors with increasing consumption of these nutrients. The
patients were treated by their surgeons along conventional
lines with either mastectomy or lumpectomy and radio-
therapy. Most of those with involved lymph nodes had
adjuvant systemic therapy - either tamoxifen or chemo-
therapy. No specific regimens of diet therapy were imple-
mented; however, some patients may have used their own
initiative to change their diet subsequent to their diagnosis
and treatment.
More than 6 years have now elapsed. No further patient
contact has been made following the initial assessment 3
months after their surgery; however, mortality data for the
state of Western Australia were accessed to determine any
deaths which had occurred among these women. Mortality
for the highest, intermediate and lowest tertile of each nut-
rient studied was computed and is presented in this article.
Method
Patients
One hundred and three women were included in the study.
This includes the 91 women in the preceding study (Ingram
et al., 1992), as well as a further 12 on whom dietary but no
histopathological data were available. These women had been
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identified from the records at the Queen Elizabeth II Medical
Centre, Perth, Western Australia, in 1985 and 1986. Three
months after operation for their primary lesion, the women
were interviewed at home using a structured questionnaire,
and each woman completed a food frequency questionnaire
in regard to her dietary habits up until the time of her breast
cancer diagnosis.
Nutritional consumption
After verbal instruction and demonstration of standard por-
tion sizes, each woman completed the questionnaire in her
own time and returned the completed questionnaire by post.
Returned questionnaires were checked for completeness and
any problems resolved by telephone. The food frequency
questionnaire identified 179 different foods and was scored
for portion size and frequency of consumption. Despite this,
in two subjects the dietary data were incomplete and so these
were excluded from the dietary analysis. Nutrient intakes
were calculated by the program FREQUAN, developed by
the Commonwealth Scientific and Industrial Research Or-
ganisation Division of Human Nutrition (Baghurst &
Record, 1984). This is based on the food tables of McCance
and Widdowson, although for sources of fat, Australian
values were substituted where data were available.
Mortality data
Access was gained to the computerised mortality data com-
piled by the Australian Bureau of Statistics. Each of the 103
women included in this study was searched on this database,
which provides information on the date and certified cause of
all deaths in Western Australia. In cases where the patient
had died, the date of her death and whether it was related to
her breast cancer was recorded.
Statistical analysis
The data were entered into a personal computer and
analysed using the program EPILOG (Epicenter Software,
Pasadena, CA, USA). The probability of survival was cal-
culated by Kaplan-Meier estimate, using a log-rank statistic.
Results
Mortality
Of the 103 subjects, 27 had died. Of these, 21 had died with
advanced breast cancer and six from other causes. These
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cases were censored in the analyses. The median duration of
follow-up was 81 months (range 71-98 months).
Nutritional associations (Tables I and II)
The most important findings from the nutrient consumption
assessment were associated with vitamin consumption, in
particular beta-carotene and vitamin C. At high levels of
consumption, there were significantly fewer deaths from
breast cancer: only one in the group of highest beta-carotene
consumers compared with eight in the intermediate group
and 12 in the lowest group (trend P = 0.0012) (Figure 1). The
equivalent figures for vitamin C were 3, 7 and 11 deaths for
the highest, intermediate and lowest consumption groups
respectively (trend P = 0.0286). Not surprisingly, these figures
are reflected to the level of fruit consumption in the food
group analyses. There were 12 deaths in the lowest total fruit
consumption group, compared with five in the intermediate
group and three in the highest (trend P = 0.0107) (Figure 2).
This benefit applied to both orange/yellow fruit (oranges,
melon, stonefruits) as well as other fruits (apple, banana,
berries, grapes, dried fruits). No other nutrient or food group
reached significance, although there appeared to be a higher
mortality at high levels of consumption of eggs and red
meats in the food group analyses.
Discussion
The observation that the type of diet consumed influences
survival from breast cancer is not surprising. Several previous
studies have demonstrated associations between diet and pro-
gnostic factors (Verreault et al., 1988; Holm et al., 1989;
Ingram et al., 1992). Verreault et al. found that a high
saturated fat intake was associated with increased node
involvement, with the converse being true for polyun-
saturated fat. Holm et al. found that low fibre intake was
associated with larger tumours and oestrogen receptor
negativity with low carbohydrate and retinol intake. In our
study (Ingram et al., 1992) we demonstrated a strong associa-
tion for beta-carotene consumption and for vitamin C con-
sumption, and a degree of improvement in differentiation
with increasing consumption of these nutrients. The current
finding of improved survival with a high consumption of
beta-carotene and of vitamin C is therefore not unexpected,
given the fact that tumour differentiation is one of the best
predictors of prognosis. It is nevertheless reassuring to find
that our initial observation is confirmed with survival. What
is unknown is whether this population continued with their
original diet, or subsequently changed, as they were not
reassessed after the initial interview. Is the diet at time of
surgery important, or is it necessary that these patients con-
tinue their diet in the post-surgery years to gain benefit?
Table I Nutrient variables
Lowest tertile Middle tertile Highest tertile
ofconsumption ofconsunption ofconsumption
No deaths No deaths No deaths P-value P-value
Nutrient variable (OIE ratio) (OIE ratio) (OIE ratio) homogeneity trend
Energy (kJday-') 8 (1.2) 6 (0.8) 7 (1.0) 0.7498 0.80
Total carbohydrate (gday-') 10 (1.5) 3 (0.4) 8 (1.1) 0.0941 0.63
Sugars (gday-') 10 (1.5) 5 (0.7) 6 (0.8) 0.2635 0.23
Starches (gday-') 7 (1.1) 9 (1.2) 5 (0.7) 0.6157 0.62
Protein (gday-') 7 (1.1) 9 (1.2) 5 (0.7) 0.5405 0.43
Total fat (gday-') 8 (1.1) 5 (0.7) 8 (1.2) 0.5526 0.96
Saturated (gday-') 7 (1.0) 5 (0.7) 9 (1.4) 0.3891 0.60
Monounsaturated (gday-') 5 (0.8) 8 (1.0) 8 (1.2) 0.7271 0.52
Polyunsaturated (gday-') 6 (0.8) 9 (1.4) 6 (0.8) 0.4194 0.96
Fibre (gday-') 10 (1.5) 7 (1.0) 4 (0.5) 0.2383 0.12
Vitamins
Retinol (unitsday-') 5 (0.7) 7 (1.0) 9 (1.3) 0.4756 0.28
Beta-carotene (pg day-') 12 (1.9) 8 (1.2) 1 (0.1) 0.0031 0.001
B, (mgday-') 8 (1.2) 11 (1.5) 2 (0.3) 0.0603 0.10
B6 (mgday-') 11 (1.8) 5 (0.6) 5 (0.7) 0.0747 0.09
C (mgday') 11 (1.6) 7 (1.0) 3 (0.4) 0.0674 0.03
E (mgday-') 8 (1.2) 8 (1.1) 5 (0.7) 0.6262 0.41
Table H Food group variables
Lowest tertile Middle tertile Highest tertile
ofconsumption ofconsumption ofconsumption
Nutrient variable No deaths No deaths No deaths P-value P-value
(gday-') (OIE ratio) (OIE ratio) (OIE ratio) homogeneity trend
Cereal products
Cakes and desserts
Dairy products (total)
Eggs
Margarine and butter
Milk products
Meat (total)
Red meat
Chicken and fish
Savouries (total)
Pizzas, stews, etc.
Chips, twisties, etc.
Fruit (total)
Yellow/orange
Other
Vegetables (total)
Leafy/orange
Starches
Fruit and vegetables (total)
7(1.0)
5 (0.7)
7(1.0)
5 (0.7)
5 (1.0)
9 (1.3)
6 (0.8)
5 (0.7)
6 (0.8)
10 (1.5)
7 (1.1)
11 (1.6)
12 (1.9)
9 (1.3)
12 (1.9)
6 (0.8)
8 (1.1)
6 (0.9)
12 (1.7)
6 (0.9)
9(1.3)
7 (1.0)
5 (0.7)
8 (0.9)
5 (0.7)
5 (0.8)
5 (0.7)
11 (1.8)
7 (1.0)
9 (1.3)
6 (0.9)
6 (0.8)
10 (1.5)
6 (0.9)
9 (1.4)
9 (1.4)
8 (1.2)
5 (0.7)
8 (1.2)
7 (1.0)
7(1.0)
11 (1.7)
8 (1.1)
7 (1.0)
10 (1.4)
11 (1.7)
4 (0.5)
4 (0.5)
5 (0.7)
4 (0.5)
3 (0.4)
2 (0.3)
3 (0.4)
6 (0.8)
4 (0.5)
7(1.0)
4 (0.6)
0.8284
0.6050
0.9997
0.0998
0.8590
0.5233
0.4786
0.1033
0.0656
0.2061
0.5278
0.1211
0.0206
0.0361
0.0228
0.5125
0.2642
0.8486
0.0555
0.83
0.78
0.90
0.08
0.93
0.68
0.33
0.11
0.63
0.10
0.56
0.06
0.01
0.05
0.01
0.94
0.30
0.88
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consumption, eight in the intermedia
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carotene is one of a large group
particularly important because it is t
carotenoid, being converted in the gu
turn is degraded to retinoic acid. R
differentiation and growth of many
Sporn & Roberts, 1983). The inducti(
been shown in embryonal carcinom
cells and numerous epithelial tissu
proliferative or growth-inhibiting effe
in vitro in a great variety ofcells, incl
mammary carcinomas (Fontana et al.
ating antiproliferative properties app
cess by which retinoids suppress ti
malignant phenotype in vitro and in v
which retinoic acid affects cell di
understood, but in recent years a
receptors (RARs) has been discove
advancing our understanding of the
signal transduction.
From a clinical point of view, a i
demonstrated a beneficial effect of
tion in breast cancer development.
High have investigated both serum concentrations of retinoids and
beta-carotene and the consumption of these nutrients in rela-
Intermediate tion to breast cancer development. The Finnish Social
Insurance Institution's Mobile Clinic collected blood samples
from 23,000 women from 1968 to 1971. Subsequently 67
women developed breast cancer and were each matched with
two controls. The samples were then analysed for retinol,
beta-carotene, alpha-tocopherol and selenium. The relative
risks for retinol and alpha-tocopherol were close to 1.0, but
for selenium the risk was 1.7, and for beta-carotene 0.4. This
beneficial effect of beta-carotene remained statistically
I I I significant after adjusting for other variables (Hakama et al., 825 2,190 2,555 2,920 1990). Similarly, a recent case-control study from Buffalo,
USA, demonstrated that breast cancer patients had lower
beta-carotene serum concentrations than control women
rves for breast cancer (P = 0.02) (Potischmann et al., 1990). Howe et al. (1990)
mLediate and lowest ter- undertook a combined analysis of 12 case-control studies of
e, eight and 12 breast dietary factors and risk of breast cancer. They demonstrated
urred in these groups a protective effect for vitamin A, vitamin C and beta-
carotene consumption, but not retinol. The relative risk for
vitamin A was 0.87 (P = 0.04), for beta-carotene 0.85
(P = 0.007) and for retinol 1.04 (P = 0.52). More recently,
the Nurses Health Study reported that there was a significant
reduction in breast cancer risk (RR 0.84, P<0.001) for the
High highest quintile of vitamin A intake, in their very large
nIntermediate cohort study (Hunter, 1993).
As regards treatment, activity of retinoids is seen in a large
LL_,_~ ~ow spectrum of tumours. Complete response rates to retinoic
acid of the order of 90% have been achieved in acute pro-
myelocytic leukaemia, a disease in which a specific
chromosomal translocation involving the retinoic acid recep-
tor alpha (RAR-a) gene occurs (Warrel et al., 1991; Kastner
et al., 1992). In addition, significant clinical responses have
been observed in cutaneous T-cell malignancies, chronic
myelogenous leukaemia and dermatological malignancies.
I,825 2,190 2,555 2,920 High objective response rates have been produced with com-
bined 13-cis-retinoic acid and alpha-interferon in patients
with squamous cell carcinoma of the skin (Lippman et al.,
rves for breast cancer 1992a) and of the cervix (Lippman et al., 1992b).
rmnediate and lowest ter- While chemoprevention trials using beta-carotene have
six and 12 breast cancer been initiated for many malignancies (Kelloff et al., 1992),
d in these groups there have been none for breast cancer, although a trial of a
retinoic acid derivative is currently under way in Italy with
the aim of evaluating any reduction in the frequency of
contralateral breast cancer in patients with previously treated
primary breast cancer (Veronesi et al., 1992). Our data
indicate that beta-carotene consumption may be useful either
I food groups are con- in reducing the chances of recurrence of breast cancer or as a
ne consumption has the chemopreventative agent in primary breast cancer. Ran-
irvival. There were 12 domised trials are needed to determine whether this is the
of lowest beta-carotene case.
tte and only one in the Finally, it should be pointed out that, while beta-carotene
of beta-carotene. Beta- has been identified in this study as the most significant
of carotenoids, but is variable investigated, it may well be that it is only a marker
:he major provitamin A of fruit consumption, and that there may be some other
it to vitamin A. This in factor in fruit which is the reason for the reduced mortality
Letinoic acid affects the as demonstrated in the figures. Alternatively, fruit consump-
y tissues (Lotan, 1980; tion tends to be inversely correlated with consumption of
on of differentiation has fat-containing foods, and it may be that the effects seen here
La cells lines, leukaemic are not due to the fruit consumption at all, but are due to the
ies. In addition, anti- high consumption of fat-containing foods. Although fat iself
xts have been observed did not appear as a significant variable, the numbers in the
uding lines derived from study are low, and it is ofinterest that retinol consumption, a
1988). Such differenti- strong marker of fat consumption, is inversely correlated
ear central to the pro- with survival.
he development of the
Pivo. The mechanisms by
ifferentiation is poorly
family of retinoic acid
,red and characterised,
process of retinoic acid
number of studies have
beta-carotene consump-
Epidemiological studies
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